Related Experiment Video
Updated: Dec 29, 2025
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?
Abdullah Al Emran1,2, Hsin-Yi Tseng1,2, Mikaela C Coleman3,4
1Melanoma Immunology and Oncology Group, The Centenary Institute, Royal Prince Alfred Hospital, University of Sydney, Camperdown, New South Wales, Australia.
Abstract:
Melanoma, as for many other cancers, undergoes a selection process during progression that limits many innate and adaptive tumor control mechanisms. Immunotherapy with immune checkpoint blockade overcomes one of the escape mechanisms but if the tumor is not eliminated other escape mechanisms evolve that require new approaches for tumor control. Some of the innate mechanisms that have evolved against infections with microorganisms and viruses are proving to be active against cancer cells but require better understanding of how they are activated and what inhibitory mechanisms may need to be targeted. This is particularly so for inflammasomes which have evolved against many different organisms and which recruit a number of cytotoxic mechanisms that remain poorly understood. Equally important is understanding of where these mechanisms will fit into existing treatment strategies and whether existing strategies already involve the innate killing mechanisms.
Insights
Cancer cells, like melanoma, develop defenses against the immune system. Understanding innate immune mechanisms, such as inflammasomes, is crucial for developing new cancer therapies beyond current immunotherapies.
Area of Science:
- Immunology
- Oncology
- Cancer Biology
Background:
- Cancer progression involves tumor cells evading immune surveillance through various escape mechanisms.
- Immune checkpoint blockade therapy is effective but not always curative, necessitating exploration of alternative anti-cancer strategies.
- Innate immune mechanisms, originally evolved to combat pathogens, show potential in targeting cancer cells.
Purpose of the Study:
- To explore the role of innate immune mechanisms, specifically inflammasomes, in cancer control.
- To understand the activation pathways and inhibitory mechanisms of inflammasomes against cancer.
- To determine how innate immune mechanisms can be integrated into existing cancer treatment strategies.
Main Methods:
- Review of current literature on cancer immune evasion and innate immunity.
- Analysis of inflammasome activation pathways and their cytotoxic effector functions.
- Evaluation of potential therapeutic targets within innate immune signaling for cancer treatment.
Main Results:
- Innate immune systems possess mechanisms, including inflammasomes, that can target cancer cells.
- Inflammasome activation recruits cytotoxic components, but their precise roles in cancer are not fully elucidated.
- Further research is needed to understand how to leverage these innate mechanisms effectively.
Conclusions:
- Targeting innate immune pathways, particularly inflammasomes, represents a promising avenue for novel cancer therapies.
- Integrating knowledge of inflammasome function into current treatment paradigms may enhance anti-tumor responses.
- Further investigation into inflammasome activation and regulation is essential for optimizing cancer immunotherapy.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
01:17The Extrinsic Apoptotic Pathway
01:28Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
01:30Apoptosis
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:17Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...